Axogen, Inc. — Director's Dealing 2020

Sep 8, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Axogen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2020-09-03

Reporting Person: Gold Mark Stephen (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-09-03	Common Stock	A	2591	$11.75	Acquired	311862	Direct

Footnotes

F1: The shares of common stock for Dr. Gold include 175,171 shares held jointly by Dr. Gold and his wife, indirect ownership of 20,000 shares held by Dr. Gold's spouse and indirect ownership of 92,000 shares held by MJSK, Ltd., a decedent investment trust held by Dr. Gold's family. The transaction reflected on this Form 4 relates to the number of restricted stock units that became vested as of September 3, 2020.